Most complex trait-associated variants are located in non-coding regulatory regions of the genome, where they have been shown to disrupt transcription factor (TF)-DNA binding motifs. Variable TF-DNA interactions are therefore increasingly considered as key drivers of phenotypic variation. However, recent genome-wide studies revealed that the majority of variable TF-DNA binding events are not driven by sequence alterations in the motif of the studied TF. This observation implies that the molecular mechanisms underlying TF-DNA binding variation and, by extrapolation, interindividual phenotypic variation are more complex than originally anticipated. Here, we summarize the findings that led to this important paradigm shift and review proposed mechanisms for local, proximal, or distal genetic variation-driven variable TF-DNA binding. In addition, we discuss the biomedical implications of these findings for our ability to dissect the molecular role(s) of noncoding genetic variants in complex traits, including disease susceptibility. In this Review, we summarize the findings that led to this increasingly accepted notion of the importance of variation in TF-DNA binding in mediating phenotypic diversity. In addition, we strive to clarify why, for the majority of studied traits or diseases, establishing a mechanistic link between regulatory and phenotypic variation is still very challenging.
Introduction

Analysis of genomic variation in humans (
In this Review, we summarize the findings that led to this increasingly accepted notion of the importance of variation in TF-DNA binding in mediating phenotypic diversity. In addition, we strive to clarify why, for the majority of studied traits or diseases, establishing a mechanistic link between regulatory and phenotypic variation is still very challenging.
For this purpose, we explore the molecular mechanisms mediating TF-DNA binding variation and address a major question in the field-namely, why the majority of variable TF-DNA binding events appear to be driven by mechanisms other than nucleotide variation in the cognate motifs. We thereby focus on human interindividual, molecular variation and restrict this Review to discussing mechanisms underlying variable TF-DNA binding. Consequently, we will only briefly cover the functional consequences of this variation or other modes of regulatory variation, which have been extensively detailed elsewhere both for humans and model organisms (Albert and 
A Brief Historical Perspective on Variable TF-DNA Interactions as Key Drivers of Inter-individual, Phenotypic Diversity
The discovery of regulatory sequences (or ''operators'') in bacteria by Jacob and Monod initiated the debate of whether variation in ''regulator-operator'' interactions could drive phenotypic diversity (Jacob and Monod, 1961). It was proposed that this variation could arise either through mutations in the regulator itself or through mutations in the operator that would ''alter or abolish its specific affinity for the repressor (i.e., regulator)'' (Jacob and Monod, 1961). This fundamental prediction proved to be accurate across species, and multiple examples have since been revealed that support both scenarios (Barrera et al., 2016; Hoekstra and Coyne, 2007; Lynch and Wagner, 2008; Wray, 2007) . The first concrete evidence supporting the importance of such non-coding or regulatory variation for human traits or diseases started to emerge in the early 1980s, when the molecular mechanisms underlying thalassemias were investigated. These heritable blood disorders, characterized by an abnormal form of hemoglobin, made it intuitive to explore the globin gene locus for disease-causing genetic variants. Numerous variants were detected, including several polymorphisms in the b globin gene (HBB) promoter that correlated with reduced HBB expression (Orkin et al., 1982; Poncz et al., 1982) . For example, a single nucleotide substitution (C to G) at position À87 of HBB's transcription start site (Orkin et al., 1982) was hypothesized to affect the recruitment of a transcriptional activator. However, it was only 11 years later, when the erythroid Krü ppel-like factor (KLF1) was cloned, that the affected site (CA(C/G)CC) was matched with a TF (Miller and Bieker, 1993) ( Table 1) . This groundbreaking example (as well as several others listed in Table 1 ) support the idea of TF-DNA interactions being key drivers of phenotypic variation. However, the fact that the underlying molecular mechanisms were uncovered for these diseases is still more the exception than the rule.
Assessing the Impact of Genetic Variation on TF-DNA Binding: A Complex Affair
The ability to elucidate the molecular mechanisms underlying thalassemia, haemophila B, or malaria resistance was made possible because several critical pieces of information were available that are often missing in other genotype-phenotype relationship studies: (1) knowledge of the affected gene, which facilitated the identification of the causal mutation(s); (2) availability of DNA binding specificity data for the implicated TF; and (3) relatively straightforward imputation of the effect of the causal mutation(s) on TF-DNA binding. Below, we will discuss each of these three items in more detail and explain why they collectively complicate studies that investigate the impact of genetic variation on molecular or organismal variation. Identification of Causal Mutation(s) and Affected Gene(s) In contrast to cases like the thalassemia mutations discussed above, GWAS studies identify genetic variants linked to particular traits, but not necessarily those actually causing the disease (Manolio, 2013). In addition, such studies do generally have little prior knowledge regarding which genes will be uncovered. Therefore, by simply matching a GWAS SNP with a TF binding site, one risks wrongly inferring that a TF must affect the expression of the gene that is most proximal to a particular binding site. However, the actual culprit could be another genetically linked but unprobed variant such as an indel or a rare SNP that impacts a different binding site and thus a distinct TF and/or target gene. This potential misidentification is why significant efforts are currently undertaken to fine-map complex traits using statistical arguments (Figure 1 ; see also the ''Imputing DNA binding variation'' section) and/or integrative genomic approaches to identify causal variants and their target genes at nucleotide-level resolution. A striking recent example involves variants that have been consistently associated with an elevated body mass index in both children and adults (Dina et al., 2007; Frayling et al., 2007) . These variants are located in the first and second introns of a large (>250 kb) gene named fatso, or FTO, because its deletion causes a fused toes phenotype in mouse (Peters et al., 1999) . Given its association with obesity, it was subsequently rephrased as fat mass and obesity-associated gene and was widely mechanistically studied for its role in energy homeostasis (Fischer et al., 2009 . The resulting motifs proved to be highly diverse in terms of nucleotide composition and exhibited extensive degeneracy, which means that these motifs can be represented by many different sequences and that small internal perturbations in these motifs tend to have little impact on DNA binding. Consequently, there is still ample room for alternative approaches or technologies that will enable the further expansion or fine-tuning of the current catalog of human TF PWMs, also named the ''human regulatory lexicon.'' Nevertheless, it may not be necessary to gather experimental data for all TFs, given that many have nearly identical DNA binding properties because their DBDs are highly similar. Indeed, TFs (independent of organism) whose DBDs share >87.5% of their amino acids were found to bind to motifs that were almost indistinguishable from one another (Weirauch et al., 2014) . Applying this principle to human TFs adds another 200 inferred motifs to the current catalog, which can be found in the Cis-BP database (Weirauch et al., 2014) . In sum, the DNA binding properties of a significant fraction of human TFs remain uncharacterized without even taking into account heterodimer or higher-order complex formation (see main text).
have important consequences in terms of predicting DNA binding events, since motif-scanning tools typically penalize for local nucleotide composition biases. Instead, a better practice may now involve rewarding motifs that are surrounded by established DNA binding-promoting features, such as a high GC fraction or lower-scoring and thus weaker homotypic (i.e., similar) motifs. Together, these studies illustrate that the formulation of DNA binding models and computational detection of genuine binding sites is far from trivial and that further efforts aimed at integrating a wide range of genomic datasets will be required to increase the robustness of motif definition and mapping approaches. (Figure 1 and Table S1 ). The greater this difference, the greater the predicted impact of the variant on binding of the respective TF and thus also the greater the likelihood of it being causal.
More recent machine learning methods no longer depend on the use of a strict motif database and directly infer regulatory effects from k-mer vocabularies trained on ChIP-seq or other experimental data. These vocabularies consist of all possible DNA sequences of length k that collectively capture specific sequence properties of certain regulatory elements such as cell-type-specific enhancers. This methodological development stems from the general appreciation in the field that the motif alone cannot accurately predict differential DNA binding and thus should be complemented (or even replaced) with information on the sequence environment around the focal variant, as well as on other DNA or chromatin features that enhance the model's overall predictive power (as already covered in the previous section). Indeed, it is now well accepted that only a minority et al., 2013) . This is consistent with an earlier study demonstrating that the TF Kaiso is capable of binding not only to an unmethylated motif, TCCTGCNA, but also to a methylated, clearly distinct palindromic motif, TCTmCGmCGAGA, with even greater affinity (Raghav et al., 2012) . How frequently such methylation-dependent changes in DNA binding occur and the extent to which other DNA modifications affect DNA binding specificities is still a matter of debate. Nevertheless, it is clear that it adds another complexity in linking DNA variation to variable TF binding.
Ongoing computational studies are attempting to take these complexities into account by implementing ''big data'' analyses that are creating extended machine learning models that rely on multilayered information of different types of genomic data, including TF motifs, DNase hypersensitivity sites (DHS), chromatin marks, etc. (see, for example, Table S1 ). As such, they can recognize regulatory regions based not only on pure sequence information, but also on the chromatin state of the DNA both at the variant locus as well as at neighboring regions. Once correctly trained, these approaches can be very precise and predict causal variants and their effects at distinct molecular levels (Alipanahi et al., 2015; Zhou and Troyanskaya, 2015) (Figure 1) . However, it is important to emphasize that their performance depends not only on the diversity of input data, but also on the correct selection of relevant features. For example, it has been repeatedly shown that it is crucial to gather data that are specific to the variant-linked trait or disease in terms of cell type, differentiation stage, tissue, or species since regulatory activity is variable and context dependent (Consortium, 2012; Maurano et al., 2015). Another limitation of these extended representation models that may dampen their widespread implementation is their inherent ''black box'' nature. Indeed, most of the binding patterns that were unveiled by these techniques are difficult to interpret, especially when no visual representation is provided. However, despite these caveats, advanced models have the potential of uncovering completely novel and potentially unexpected cross-mechanisms that more standard methodologies may fail to grasp. . We would thereby like to argue that, for the sake of discussion and molecular understanding, it might be valuable to differentiate between these two terms (Figure 2) . Local, Cooperative TF-DNA Binding In the context of protein-DNA interactions, cooperativity was initially used in describing the assembly of E. coli lambda repressors on DNA (Ptashne et al., 1980) . Binding of a lambda dimer on a first operator site facilitates binding of another lambda dimer on the second operator site, given that physical interactions between the first and second dimer increase the affinity of the latter for DNA, which explains why ''cooperative DNA binding'' is evoked to define this process. Consequently, the term cooperativity may be especially suited for DNA binding processes that involve TFs whose physical interactions at the protein level may increase the affinity of the entire complex to specific sites in the genome. For example, binding of the winged HTH DNA binding domain-containing TF IRF4 is cooperatively enhanced by the TF PU.1 (Escalante et al., 2002) . This is because binding of the two TFs contorts the DNA in a peculiar S shape, placing the TFs in an optimal position for electrostatic and hydrophobic interactions and thus stabilizing the entire complex (Escalante et al., 2002) . Consequently, individual It is therefore valuable to explore approaches to study the molecular origin of both short-and especially long-range TF-DNA binding variation. One such approach is the identification of genetic polymorphisms that significantly correlate with changes in DNA occupancy. Genomic regions in which such variants are located are interchangeably termed TF or binding quantitative trait loci (tfQTLs or bQTLs), as their detection suggests that a polymorphism within this locus causally affects the ability of a TF to bind to DNA. One study adopting this approach aimed to identify variants that affect DNA binding of the insulator protein CTCF by profiling its binding landscape in human LCLs using ChIP-seq, after which tfQTLs were explored within a 50 kb region centered around the CTCF binding region (Ding et al., 2014) . Only a minority of detected tfQTLs overlapped the CTCF motif, even when the local LD structure was taken into account. A similar picture emerged from a comparable study on PU.1 DNA binding variation also in human LCLs, since PU.1 tfQTLs exhibited a bimodal log-normal distribution in terms of their distance to the PU.1 binding region (Waszak et al., 2015) . The first mode represented tfQTLs that were located close to or at the PU.1 binding site and, consistent with the CTCF study, encompassed only a minority of the significantly associated variants. The second mode featured tfQTLs that were located distally to the PU.1 binding region with a median distance between 20 and 30 kb. Together, these findings suggest that many variable CTCF or PU.1 binding events are driven by long-distance mechanisms, which renders TF-DNA binding a complex molecular trait by itself. Consequently, and even though the effect size of distal tfQTLs tends to be inferior to that of proximal ones (Waszak et al., 2015) , it will be valuable to decipher how these distal variants affect TF-DNA binding, given that they constitute the majority of DNA binding QTLs.
TF-DNA
In the LCLs, PU.1 binding variation often correlated with variation in active chromatin marks such as H3K4me1 or H3K27ac-not only locally, but often over extended distances (Waszak et al., 2015) . That is, high PU.1 DNA occupancy coincided with both high proximal and distal H3K4me1 and H3K27ac enrichment and vice versa. Such regions with a high level of molecular coordination between TF and chromatin marks have recently been termed ''variable chromatin modules'' (VCMs; Waszak et al., 2015; Figure 3A) . Each VCM is thus composed of molecular phenotypes (e.g., the level of DNA occupancy by a TF or enrichment for a specific chromatin mark) that are highly coordinated, often over multiple kbp of DNA. More than 14,000 distinct VCMs were discovered in human LCLs, covering about 5% of the genome (Waszak et al., 2015) . The majority of these were ''totem'' VCMs-so named because they were composed of stacked or overlapping molecular phenotypes that did not correlate with other neighboring molecular phenotypes. Thus, a totem VCM represents local chromatin state variation ( Figure 3A) . The remaining ''multi-VCMs'' are more interesting since, while a minority, they typically cover two or more distinct regulatory elements-hence the term ''multi''-and capture the majority of all detected molecular phenotypes ( Figure 3A) . The origin of a ''multi-VCM'' is less intuitive than that of a totem-VCM. Its structure suggests, however, a higher-order chromatin organization that is reminiscent of the modular genomic structure that has been uncovered in the form of topologically associating domains (TADs) (Dixon et al., 2012; Nora et al., 2012) .
These TADs constitute distinct, three-dimensional genomic structures in which sequences are more likely to interact with one another than with those located outside the respective TAD. However, VCMs and TADs constitute different molecular entities because VCMs tend to be embedded within TADs and thus tend to be smaller ( Figure 3B) . Moreover, the more regulatory elements encompassed in a VCM, the more likely it was to associate with variable gene expression. Together, the conceptual similarities between sub-TADs and multi-VCMs suggest that the latter also reflect fine-grained configurations of interacting regulatory elements with one or a few target genes whose collective, molecular activity is highly coordinated. As such, VCMs may provide substantial insights into the structural and thus modular organization of the chromatin landscape, including TF-DNA interactions.
Which mechanisms lie at the origin of multi-VCMs? Since the long-range molecular coordination that typifies multi-VCMs has been observed at the allelic level (Kasowski et al., 2013; Kilpinen et al., 2013; McVicker et al., 2013) and since recent chromatin interaction analysis by paired-end tag sequencing (ChIA-PET) data has also provided evidence for allele-specific chromatin topologies (Tang et al., 2015) , it is reasonable to assume that the observed molecular variation is largely driven by genetic factors. Moreover, most of the molecular variation within each VCM could be captured by a single, quantitative phenotype (Waszak et al., 2015) , which suggests that the activity state of a VCM can be attributed to relatively few but strong causal variants. QTL mapping using the activity state of each VCM as input yielded vcmQTLs that were highly enriched in TF-occupied regions (Waszak et al., 2015) (Figure 3A) . Together with previous Figure 3B) . Thus, the ability of a TF to bind to a VCM-associated genomic region appears to be a function of the respective VCM's activity state, which itself seems determined by one or few key TFs. As such, VCMs provide a conceptual framework to rationalize how distal genetic variation can affect TF-DNA binding.
Defining these key TFs remains a work in progress, since only few TFs reached significant enrichment in terms of their overlap with vcmQTLs (Waszak et al., 2015) . This suggests that each VCM may have its own set of activity-determining TFs. Interestingly, distinct pairs of these same TFs were also enriched at pairs of regulatory elements that belonged to the same VCM ( 
From Causal Variant to Complex Phenotype
While the identification and characterization of a trait-or disease-associated variant that causally disrupts TF-DNA binding is difficult, elucidating how it impacts on other potentially downstream molecular and biological processes may be equally if not more challenging (Edwards et al., 2013) . One intuitive strategy to expand on the relatively few cases so far in which a causal relationship between molecular and phenotypic variation was established (Table 1) is the integration of other genetic or molecular data to infer the functional consequences of the focal variant.
For example, distinct QTL datasets can be used to determine whether the variant impacts not only TF-DNA binding, but also the chromatin landscape, gene expression, or even other molecular phenotypes (Pai et al., 2015) . The most common molecular QTL analysis, involving the identification of variants that associate with gene expression changes (i.e., eQTLs), is highly informative in this regard. For six distinct human populations, the most significant eQTLs were consistently found to overlap TF binding sites (Auton et al., 2015) , thus providing direct insights into the identity of genes whose expression may be affected by variable TF-DNA binding.
However, other layers of molecular phenotypes-more associated with regulatory functions and therefore often defined as regulatory QTLs-can also be associated with genotypes. These include: ( . However, in most cases, the causal variants are obviously unknown a priori. To identify them, it may prove valuable to, similar to eQTLs, map VCMs in as many distinct cell types/tissues as possible. The resulting set of VCMs may then provide guidance to both variant identification and characterization. Indeed, the most interesting candidates among the set of associated GWAS variants would be those that impact not only on the chromatin topology (e.g., vcmQTLs) and state of the respective locus (e.g., cQTLs or tfQTLs), but also on expression of the embedded gene. Once identified, it should be relatively straightforward to detangle the underlying molecular mechanisms since the coordinated, molecular phenotypes that make up the focal VCM should provide clear insights into the flow of regulatory information, i.e., from causal nucleotide over gene to ultimately cellular or organismal phenotype.
Conclusions
The fundamental discovery that most complex trait-associated variants are located in non-coding, putatively regulatory regions of the genome has focused the spotlight on TF-DNA interactions as important mediators of phenotypic variation. Yet, to date, relatively few examples are available in which a clear mechanistic relationship between TF-DNA binding variation and phenotypic variation was established (Table 1) . To clarify why this is such a challenging task, we focused in this Review on elucidating how the impact of genetic variation on TF-DNA binding can be assessed and why, contrary to expectations, this is itself already inherently complex. There are several current limitations that will have to be addressed to improve our ability to identify and interpret regulatory variation, including the need for new experimental or computational approaches that will enable us to expand the TF motif catalog, to better predict genuine TF binding sites, and to evaluate how motif variation affects TF-DNA binding. Promising research avenues in this regard include the development of new technologies to characterize monomeric and higher complex TF-DNA binding properties and the incorporation of additional DNA binding features such as the sequence environment and the conformational and chemical nature of DNA in machine learning approaches. In addition, it is increasingly appreciated that the chromatin context needs to be accounted for when searching for causal, regulatory variants and that, in general, the use of cell types or systems that are most relevant for the studied trait or disease will yield the best results. It is also important to recognize that only a small fraction of all variable TF-DNA binding events is actually driven by variation within the motif of the studied TF. Thus, similar to gene expression, TF-DNA binding is a complex molecular trait by itself, which has profound implications for our understanding of how regulatory variation arises.
Well-established concepts in the gene regulation field provide an intuitive molecular foundation for local or proximal variantdriven DNA binding variation. Specifically, the former involves cooperative DNA binding that is mediated by direct, physical interactions between TFs, while the latter appears to be driven by collaborative DNA binding that is likely reflective of sequenceor chromatin-context conditioned TF interdependencies to displace nucleosomes and open chromatin. However, the mechanisms that underlie distal variant-driven DNA binding changes are much less well understood (Figure 2) . The identification of 3C-, ChIA-PET-, or VCM-based chromatin entities that link structural information to transcriptional function is important in this regard since they offer a molecular rationale to explain these prevalent, long-range DNA binding dependencies. Sustained efforts will therefore be required to unravel the modular structure of the variable (epi)genome across a wide range of cells or tissues. Thus, although many challenges remain, exciting progress is being made in elucidating the genetic basis of TF-DNA binding variation that will undoubtedly improve our ability to achieve a nucleotide-level understanding of the molecular mechanisms underlying many complex traits, including disease susceptibility. 
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